The market is heading into a busy second half of December, with multiple upcoming IPOs, IPO listings, allotments and open public issues lined up across sectors such as pharmaceuticals, healthcare, asset management, consumer durables and manufacturing.
Investor interest is quite steady, as several issues are set to open next week, while recently closed IPOs are preparing for listing amid healthy grey market premiums.
KSH International IPO to Open Next Week
Among the upcoming IPOs opening next week, the KSH International IPO will open for subscription on December 16 and close on December 18. Incorporated in 1979, KSH International Limited is India’s third-largest manufacturer and the largest exporter of magnet winding wires, supplying to OEMs across power, renewable energy, railways, automotive and industrial sectors. The public issue is a book-built IPO of Rs. 710 crore, with a price band fixed at Rs. 365 to Rs. 384 per share. The KSH International IPO allotment is expected to be finalised on December 19, while the stock is scheduled to list on BSE and NSE on December 23, 2025.
IPOs Closed and Set to List: Corona Remedies, Wakefit Innovations
Corona Remedies IPO is scheduled to list on BSE and NSE on December 15. The issue opened for bidding on December 8 and closed on December 10, with the allotment finalised on December 11. The pharma IPO was a book-built issue of Rs. 655.37 crore, priced at Rs. 1,062 per share.
In the grey market, the Corona Remedies IPO GMP remains strong at Rs. 305, last updated on December 14, indicating an expected listing gain of around 28.72%. Corona Remedies Limited operates in women’s healthcare, cardiology, pain management, urology and other therapeutic segments.
Wakefit Innovations IPO will also debut on December 15, after its bidding window closed on December 10. The Wakefit IPO was subscribed 2.52 times overall, with strong demand in the retail and QIB categories. The public issue size stood at Rs. 1,288.89 crore, with a price band of Rs. 195 per share.
The Wakefit Innovations IPO GMP is currently Rs. 7, pointing to a modest expected gain of 3.59%, as investors remain selective in consumer-focused listings.
IPO Allotments and Listings Next Week: Park Medi World, Nephrocare Health
Among IPOs where allotment and listing are due next week, the Park Medi World IPO is expected to finalise allotment on December 15, with listing scheduled for December 17. The issue is a Rs. 920 crore book-built IPO, priced in the range of Rs. 154 to Rs. 162 per share.
Park Mediworld Limited operates a chain of private hospitals primarily across North India. The Park Medi World IPO GMP stands at Rs. 7, indicating a potential listing gain of about 4.32%.
Similarly, the Nephrocare Health IPO will also see allotment on December 15 and listing on December 17, 2025. The IPO size is Rs. 871.05 crore, with a price band of Rs. 438 to Rs. 460 per share. The Nephrocare Health IPO GMP is currently Rs. 33, translating into an expected gain of around 7.17%, as per the latest grey market trends.
Open IPO: ICICI Prudential AMC IPO Subscription Status
The ICICI Prudential AMC IPO, one of the largest issues of the year, is currently open for subscription. The IPO opened on December 12, 2025, and will close on December 16. The issue size stands at a massive Rs. 10,602.65 crore.
The ICICI Prudential AMC IPO price band is fixed at Rs. 2,061 to Rs. 2,165 per share. As of December 12, the issue was subscribed 0.73 times overall, with QIB demand remaining strong, while retail participation stayed muted. In the grey market, the ICICI Prudential AMC IPO GMP is around Rs. 290, last updated on December 14, suggesting an expected listing gain of about 13.39%.